Abstract
Free radicals have been suggested to play a role in adriamycin-induced cardiomyopathy. Adriamycin-induced myocardial effects were examined in rats maintained on a vitamin E deficient diet. Animals were divided into four groups: I, control; II, adriamycin-treated; III, vitamin E deficient diet; IV, vitamin E deficient diet plus adriamycin treatment. Adriamycin-treated animals (groups II and IV) were given six injections (i.p.) over two weeks for producing a cumulative dose of 15 mg/kg. Animals in groups III and IV were placed on vitamin E deficient diet starting two weeks prior to the first injection of adriamycin or vehicle. Myocardial tissue analysis were performed on animals sacrificed 1 week after the last injection. Mortality was significantly higher in group IV which also showed doubling of myocardial malondialdehyde content relative to the non-adriamycin-treated vitamin E deficient group (III). Myocardial cell damage in group IV was characterized by separation of the external lamina, subsarcolemmal changes, mitochondrial swelling and myofibril dropout. Group II hearts showed only a mild dilation of the sarcotubules and swelling of the mitochondria. Total sialic acid content of the sarcolemma in groups II, III and IV was 55, 90 and 24% of the control values in group I. These data show a characteristic sarcolemmal injury produced by adriamycin in hearts of animals with reduced antioxidant capacity which is probably mediated by increased free radical activity as well as lipid peroxidation.
Similar content being viewed by others
References
Lefrak EA, Pitha J, Rosenheim S, Gottlieb J: A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32:302–314, 1973
Cortes EP, Lutman G, Wanka J, Wang JJ, Pickren J, Wallace J, Holland JF: Adriamycin (NSC-123127) cardiotoxicity. A clinicopathologic correlation. Cancer Treat Rep 6:215–225, 1975
Von Hoff DD, Layard MW, Basa P, Davis HL, Von Hoff AL, Rozeneweig M, Muggia FM: Risk factors of doxorubicininduced congestive heart failure. Ann Intern Med 91:710–717, 1979
Goorin AM, Borow KM, Goldman A, Williams G, Henderson IC, Sallan SE, Cohen H, Jaffe N: Congestive heart failure due to adriamycin cardiotoxicity: its natural history in children. Cancer 47:2810–2816, 1981
Di Marco A: Adriamycin (NSC-123127): Mode and mechanism of action. Cancer Chemoterap Rep 6:91–106, 1975
Rosenhoff SJ, Brooks E, Bostick R, Young RE: Alterations in DNA synthesis in cardiac tissue induced by adriamycin and in vivo relationship to fatal toxicity. Biochem Pharmacol 24:1898–1901, 1975
Singal PK, Deally CMR, Weinberg LE: Subcellular effects of adriamycin in the heart: A concise review. J Mol Cell Cardiol 19:817–828, 1987
Bachur NR, Gordon SL, Gee MV: Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. Mol Pharmacol 13:901–910, 1977
Doroshow JH: Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res 43:460–472, 1983
Handa K, Sato S: Generation of free radicals of quinone group-containing anticancer chemicals in NADPH-microsome system as evidenced by initiation of sulfide oxidation. Gann 11:43, 1975
Thornalley PJ, Dodd NJF: Free radical production from normal and adriamycin-treated rat cardiac sarcosomes. Biochem Pharmacol 34:669–674, 1985
Kalyanaraman B, Perez-Reyes E, Mason RP: Spin trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs. Biochim Biophys Acta 630:119–130, 1980
Land EJ, Mukherje T, Swallow AJ, Bruce MJ: One electron reduction of adriamycin. Properties of the semiquinone. Arch Biochem Biophys 225:116–121, 1983
Winterbourn CC: Evidence for the production of hydroxyl radicals from adriamycin semiquinone and H2O2. FEBS Lett 136:89–94, 1981
Plaa GL, Witschi H: Chemicals, drugs and lipid peroxidation. Ann Rev Pharmacol Toxicol 16:125–141, 1976
Myers CE, McGuire WP, Liss RH, Ifrim I, Grutzinger K, Young RC: Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Sci 19:165–167, 1977
Weinberg LE, Singal PK: Refractory heart failure and age-related differences in adriamycin-induced myocardial changes in rats. Can J Physiol Pharmacol 65:1957–1965, 1986
Matsukubo MP, Singal PK, Dhalla NS: Negatively charged sites and calcium binding in the isolated rat heart sarcolemma. Basic Res Cardiol 76:16–28, 1981
Singal PK, Dhalla NS: Morphological methods for studying heart membranes. In Methods in studying cardiac membranes. Vol. 2, Ed. by N. S. Dhalla. CRC Press, Florida, 3–16, 1984
Placer ZA, Cushman LL, Johnson BC: Estimation of product of lipid peroxidation (malonyldialdehyde) in biochemical systems. Anal Biochem 16:359–365, 1966
Takeo S, Duke P, Taam GML, Singal PK, Dhalla NS: Effects of lanthanum on the heart sarcolemmal ATPase and calcium binding activities. Can J Physiol Pharmacol 57:496–503, 1979
Warren L: The thiobarbituric acid assay of sialic acids. J Biol Chem 234:1971–1976, 1959
Singal PK, Segstro RJ, Singh RP, Kutryk MJ: Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy. Can J Cardiol 1:139–147, 1985
Azuma J, Sperelakis N, Hasegama H, Tanimoto T, Vogel S, Ogura K, Awata N, Sawamura A, Harada H, Ishiyama T, Morita Y, Yamamura Y: Adriamycin cardiotoxicity: possible pathogenic mechanisms. J Mol Cell Cardiol 13:381–397, 1981
Singal PK, Panagia V: Direct effects of adriamycin on the rat heart sarcolemma. Res Commun Chem Pathol Pharmacol 43:67–77, 1986
Singal PK, Pierce GN: Adriamycin stimulates low-affinity Cat+ binding and lipid peroxidation but depresses myocardial function. Am J Physiol 250:H419-H425, 1986
Lehotay DC, Levey BA, Levey GS: Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs. Biomed Pharmacoth 37:312–316, 1983
Frank JS, Langer GA, Nudd LM, Serydarian K. The myocardial cell surface, its histochemistry, and the effect of sialic acid and calcium removal on its structure and cellular ionic exchange. Circ Res 41:702–714, 1977
Alto LE, Dhalla NS: Myocardial cation contents during induction of calcium paradox. Am J Physiol 237:H713-H719, 1979
Tomlinson CW, Godin DV, Rabkin SW: Adriamycin cardiomyopathy: implications of cellular changes in a canine model with mild impairment of left ventricular function. Biochem Pharmacol 34:4033–4041, 1985
Cook GM: Glycoproteins in membranes. Biol Rev 43:363–391
Long C, Movat B: The binding of calcium ions by erythrocytes and ghost — cell membranes. Biochem J 123:829–836, 1971
Shlatz L, Marinetti GV: Calcium binding to the rat liver plasma membrane. Biochim Biophys Acta 290:70–83, 1972
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singal, P.K., Tong, J. Vitamin E deficiency accentuates adriamycin-induced cardiomyopathy and cell surface changes. Mol Cell Biochem 84, 163–171 (1988). https://doi.org/10.1007/BF00421051
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00421051